pinocembrin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adu-Frimpong, M; He, Q; Ji, H; Li, X; Rong, W; Shen, X; Shi, F; Toreniyazov, E; Wang, Q; Xia, X; Xu, X; Yu, J; Zhang, J | 1 |
| Pei, B; Sun, J | 1 |
2 other study(ies) available for pinocembrin and Alloxan Diabetes
| Article | Year |
|---|---|
Preparation,
Topics: Animals; Biological Availability; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Liposomes; Mice; Particle Size; Polyethylene Glycols | 2022 |
Pinocembrin alleviates cognition deficits by inhibiting inflammation in diabetic mice.
Topics: Animals; Brain; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Experimental; Encephalitis; Flavanones; Inflammation; Male; Maze Learning; Mice; Mice, Inbred ICR | 2018 |